Search research articles
Contact Us
Filters
Showing results (521-530 of 826) with videos related to
Page
of 83
Sort By:
Journal of Substance Use and Addiction Treatment
|
January 18, 2026
Real-time peer-navigation support during community re-entry for adults with opioid use disorder
Adati Tarfa, Melissa Borker, Margaret Lancaster, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine
|
May 6, 2005
Correlates of HIV infection among incarcerated women: implications for improving detection of HIV infection
Frederick L Altice, Adrian Marinovich, Kaveh Khoshnood, et al.
Contemporary Clinical Trials
|
November 22, 2011
Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - a potential conduit to improved HIV treatment outcomes
Ali Shabahang Saber-Tehrani, Sandra A Springer, Jingjun Qiu, et al.
The Journal of Cell Biology
|
January 11, 2012
Structural specializations of α(4)β(7), an integrin that mediates rolling adhesion
Yamei Yu, Jianghai Zhu, Li-Zhi Mi, et al.
Immunity
|
April 16, 2004
Rolling adhesion through an extended conformation of integrin alphaLbeta2 and relation to alpha I and beta I-like domain interaction
Azucena Salas, Motomu Shimaoka, Avi N Kogan, et al.
Plos Genetics
|
July 25, 2009
Coevolution of interacting fertilization proteins
Nathaniel L Clark, Joe Gasper, Masashi Sekino, et al.
Blood
|
August 4, 2010
Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening
Jieqing Zhu, Jianghai Zhu, Ana Negri, et al.
Contemporary Clinical Trials
|
September 22, 2014
Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community
Angela Di Paola, Thomas Lincoln, Daniel J Skiest, et al.
JAMA Internal Medicine
|
April 2, 2014
Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate
Jaimie P Meyer, Javier Cepeda, Johnny Wu, et al.
AIDS (London, England)
|
August 23, 2020
Preventing HIV outbreaks among people who inject drugs in the United States: plus ça change, plus ça même chose
Steffanie A Strathdee, Irene Kuo, Nabila El-Bassel, et al.
Page
of 83
Search research articles
Search
Showing results (521-530 of 826) with videos related to
Sort By:
Page
of 83
Journal of Substance Use and Addiction Treatment
|
January 18, 2026
Real-time peer-navigation support during community re-entry for adults with opioid use disorder
Adati Tarfa, Melissa Borker, Margaret Lancaster, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine
|
May 6, 2005
Correlates of HIV infection among incarcerated women: implications for improving detection of HIV infection
Frederick L Altice, Adrian Marinovich, Kaveh Khoshnood, et al.
Contemporary Clinical Trials
|
November 22, 2011
Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - a potential conduit to improved HIV treatment outcomes
Ali Shabahang Saber-Tehrani, Sandra A Springer, Jingjun Qiu, et al.
The Journal of Cell Biology
|
January 11, 2012
Structural specializations of α(4)β(7), an integrin that mediates rolling adhesion
Yamei Yu, Jianghai Zhu, Li-Zhi Mi, et al.
Immunity
|
April 16, 2004
Rolling adhesion through an extended conformation of integrin alphaLbeta2 and relation to alpha I and beta I-like domain interaction
Azucena Salas, Motomu Shimaoka, Avi N Kogan, et al.
Plos Genetics
|
July 25, 2009
Coevolution of interacting fertilization proteins
Nathaniel L Clark, Joe Gasper, Masashi Sekino, et al.
Blood
|
August 4, 2010
Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening
Jieqing Zhu, Jianghai Zhu, Ana Negri, et al.
Contemporary Clinical Trials
|
September 22, 2014
Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community
Angela Di Paola, Thomas Lincoln, Daniel J Skiest, et al.
JAMA Internal Medicine
|
April 2, 2014
Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate
Jaimie P Meyer, Javier Cepeda, Johnny Wu, et al.
AIDS (London, England)
|
August 23, 2020
Preventing HIV outbreaks among people who inject drugs in the United States: plus ça change, plus ça même chose
Steffanie A Strathdee, Irene Kuo, Nabila El-Bassel, et al.
Page
of 83